Showing results (701-710 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 1, 1990
A phase I and pharmacokinetic study of intravenous vinzolidineC W Taylor, S E Salmon, W G Satterlee, et al.
Investigational New Drugs|June 27, 2013
Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) studyJ Martín-Liberal, A López-Pousa, J Martín Broto, et al.
Investigational New Drugs|May 1, 1990
Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group studyJ M Falletta, B Cushing, S Lauer, et al.
Investigational New Drugs|April 10, 2013
Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patientsDouglas A Rubinson, Howard S Hochster, David P Ryan, et al.
Investigational New Drugs|April 13, 2013
Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancerWilfried E E Eberhardt, Paul Mitchell, Joan H Schiller, et al.
Investigational New Drugs|September 23, 2014
Phase 1 combination study of eribulin mesylate with trastuzumab for advanced or recurrent human epidermal growth factor receptor 2 positive breast cancerHirofumi Mukai, Toshiaki Saeki, Ken Shimada, et al.
Investigational New Drugs|October 1, 2013
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD studyM Martin-Richard, R Gallego, C Pericay, et al.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Investigational New Drugs|October 23, 2013
Synthesis and in vitro characterization of ionone-based compounds as dual inhibitors of the androgen receptor and NF-κBWeiguo Liu, Jinming Zhou, Guoyan Geng, et al.
Investigational New Drugs|November 27, 2012
A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancerTakayuki Yoshino, Kentaro Yamazaki, Kensei Yamaguchi, et al.
Pageof 372